Correlation Between Cadrenal Therapeutics, and Reunion Neuroscience
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Reunion Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Reunion Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Reunion Neuroscience, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Reunion Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Reunion Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Reunion Neuroscience.
Diversification Opportunities for Cadrenal Therapeutics, and Reunion Neuroscience
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cadrenal and Reunion is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Reunion Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reunion Neuroscience and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Reunion Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reunion Neuroscience has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Reunion Neuroscience go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Reunion Neuroscience
If you would invest 112.00 in Reunion Neuroscience on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Reunion Neuroscience or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Reunion Neuroscience
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Reunion Neuroscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cadrenal Therapeutics, and Reunion Neuroscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Reunion Neuroscience
The main advantage of trading using opposite Cadrenal Therapeutics, and Reunion Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Reunion Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will offset losses from the drop in Reunion Neuroscience's long position.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals | Cadrenal Therapeutics, vs. Seres Therapeutics |
| Reunion Neuroscience vs. Braxia Scientific Corp | Reunion Neuroscience vs. Oxford Nanopore Technologies | Reunion Neuroscience vs. Algernon Pharmaceuticals | Reunion Neuroscience vs. Awakn Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |